English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe Board of Directors of the Rhode Island Life Science Hub has selected Mark A. Turco, MD, to be the organization’s first President and Chief Executive Officer (CEO), the organization announced today. Dr. Turco has more than 25 years of executive experience in advancing medical technology development, clinical medicine, academic research and innovation.
Tag: CEO
Machine Learning for Predicting Corporate Violations: How Do CEO Characteristics Matter?
Abstract Based on upper echelon theory, we employ machine learning to explore how CEO characteristics influence corporate violations using a large-scale dataset of listed firms in China for the period 2010–2020. Comparing ten machine learning methods, we find that eXtreme…
The more, the better: The influence of overconfident CEOs on their firms’ digital orientation
Abstract Adopting a digital orientation (DO) is an essential organizing theme for firms seeking to lay the basis for a digital transformation by defining how to nurture digitalization strategies. Existing literature reveals that CEOs determine resource allocations for digital investments, with few insights into…
ACS Executive Director and CEO Patricia L. Turner, MD, MBA, FACS, Begins Term as President of the Council of Medical Specialty Societies
Patricia L. Turner, MD, MBA, FACS, Executive Director & CEO of the American College of Surgeons (ACS), began her 1-year term as president of the Council of Medical Specialty Societies (CMSS) at the CMSS annual meeting in Chicago on November 21.
When do firms benefit from overconfident CEOs? The role of board expertise and power for technological breakthrough innovation
Abstract Research Summary While prior upper echelon research has shown that overconfident CEOs are beneficial for innovation, less is known about how firms can harness the benefits of these CEOs for breakthrough innovations. To extend this stream of research, we…
Gender and racial minorities on corporate boards: How board faultlines and CEO-minority director overlap affect firm performance
Abstract Research Summary In this article, we examine the multidimensional and multilevel nature of diversity in the context of corporate boards. Using the concept of faultlines, we argue that when gender and racial background aligns with human capital attributes of…
Why New CEO Brightens Boeing’s Stock Outlook
Boeing’s stock outlook, negatively impacted by quality-control and legal challenges, has improved with the naming of a new CEO, says Clinical Professor of Finance David Kass at the University of Maryland’s Robert H. Smith School of Business. He explains: “The…
Sysmex America Announces Dan Zortman as New CEO
Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and information systems, today announced that longtime healthcare executive Dan Zortman has been named the company’s new CEO.
Does CEO temporal myopia always lead to firm short-termism? The critical role of CEO optimism and perceived opportunity costs
Abstract Literature suggests that chief executive officers (CEOs) often discount long-term returns more than short-term gains, resulting in firm short-termism. However, the findings from previous studies are not conclusive. Drawing on upper echelons theory, we argue that a CEO’s optimism…
Failure Escape: The role of advice seeking in CEOs’ awareness of financial difficulties and corporate restructuring
Abstract This study investigates CEOs’ advice-seeking behavior in small- and medium-sized enterprises (SMEs) and its influence on managing the financial difficulties these firms face. Grounded in the attention-based view of firms, our framework posits that CEOs’ advice seeking plays a…
Hiring “problem directors” can knock up to 64% off a firm’s value
Companies that appoint directors with a track record of questionable professional conduct cause an increase in reckless corporate risk-taking and could see up to 64 per cent of a firm’s value knocked off, a new study has found.
Podcast: Down to Business Episode 101 – Robert Isom, CEO of American Airlines
On this inaugural episode of the Down to Business podcast, host Sharon F. Matusik, Edward J. Frey Dean of the Ross School of Business, is joined by Robert Isom, MBA ’91, to discuss his path to Michigan Ross, his career as a Ross MBA, his journey to becoming CEO and president of American Airlines, and his advice for current and prospective Ross students who are interested in leadership careers.
The 3rd World Marketing Forum “The New Marketingverse: Meta Mitri Meetang.”
Marketing Association of Thailand, in partnership with Asia Marketing Federation, is delighted to present the prestigious “3rd World Marketing Forum.”
Crystal S. Denlinger, MD, FACP, Named New CEO of National Comprehensive Cancer Network; Robert W. Carlson, MD, Retiring After 10+ Years Leading Global Oncology Nonprofit
The National Comprehensive Cancer Network (NCCN)—a not-for-profit alliance of leading academic cancer centers—announces Crystal S. Denlinger, MD, FACP, as incoming Chief Executive Officer (CEO), replacing the retiring longtime CEO, Robert W. Carlson, MD.
ISPOR Announces New CEO
ISPOR—The Professional Society for Health Economics and Outcomes Research announced that its Board of Directors has appointed Rob Abbott as the Society’s new CEO and executive director after an extensive search process. Mr Abbott will assume the role of ISPOR’s CEO on March 13, 2023, succeeding Nancy S. Berg who is retiring.
Prosocial CEOs increase company value, stakeholder satisfaction
New research from Weili Ge, professor of accounting at the University of Washington Foster School of Business, found that CEOs who engage in prosocial behavior — activities that primarily help others — are more likely to make decisions that benefit people and increase company value.
Boards of directors and the media generally ‘get it right’ in rewarding CEOs based on performance, study shows
The Notre Dame study looks at performance based on the impact the CEO has on the firm within the context of the performance they inherited and the time period in which they ran the firm.
Dr. Selwyn M. Vickers Named President and CEO of Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center (MSK) today announced that Selwyn M. Vickers, MD, FACS, an internationally recognized pancreatic cancer surgeon and researcher, a pioneer in cancer health disparities research, and an academic medical leader, has been selected to serve as its next President and Chief Executive Officer.
Health system CEOs form coalition to set new safety standards for U.S. health care workers
Johnese Spisso, president of UCLA Health and CEO of UCLA Hospital System, has joined forces with nine other U.S. health system leaders to form the CEO Coalition and set new safety standards for the nation’s health care workers.
Endocrine Society names Kate Fryer as Chief Executive Officer
The Endocrine Society is excited to announce the selection of Kate Fryer as the organization’s next chief executive officer. Fryer has served in numerous scientific association leadership positions with deep experience in strategic planning, membership, scientific publishing, communications, society operations, as well as meetings and conferences.
Male-dominated background affects CEOs’ decisions, new study finds
Male CEOs who experienced gender imbalance in their formative years are more likely to promote women into peripheral divisions of their companies and give them less capital, according to a recent study by W. P. Carey School of Business Professor Denis Sosyura.
Memorial Sloan Kettering Awards and Appointments
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
“America’s Medical School” Dean Arthur L. Kellermann Announces Departure
Arthur L. Kellermann, MD, MPH, the dean of the F. Edward Hébert School of Medicine — “America’s Medical School” — at the Uniformed Services University of the Health Sciences, has announced he will leave for a new position at Virginia Commonwealth University in Richmond.
Sorenson Impact Center names impact investor Geoff Davis CEO
Geoff Davis will take on the new role of CEO for the Sorenson Impact Center at the David Eccles School of Business at the University of Utah. He begins his new position on July 13, 2020.
Endocrine Society names experienced endocrinologist interim CEO
The Endocrine Society has named Robert W. Lash, M.D.—an endocrinologist with more than 25 years of experience in the field—as its interim CEO.
American College of Sports Medicine Announces Kristin Belleson as new Chief Executive Officer
Belleson joins ACSM from the American Osteopathic Association, where she served as interim chief operating officer and vice president of affiliate affairs and membership services. In her new role at ACSM, Belleson will lead the largest sports medicine and exercise science organization in the world.
The CEO-CFO Relationship and Executive Compensation
It’s not uncommon for incoming CEOs to hire new senior staff when they join companies. But when they hire new CFOs, might those CFOs be pressured to manage earnings in a way that benefits the CEOs’ pay? New research examines these C-suite relationships and what they might mean for the long-term health of a company.
Outgoing Save the Children CEO Carolyn Miles Reflects on 20 Years With Organization
University of Virginia Darden School of Business alumna Carolyn Miles says the international nonprofit Save the Children has increasingly focused on fundraising, social media marketing and the impact of programs in the 120 countries that have Save the Children representatives during her tenure as the first female president and CEO of the organization in the U.S.
Liberal or conservative? CEOs’ political leanings skew firms’ logic in structuring initial pay packages, study shows
Newly appointed, conservative CEOs who are naturally more risk averse receive less performance-based pay than those who are more willing to take risks, and more liberal CEOs get more performance-based pay, according to research from Notre Dame’s Timothy Hubbard.
Head of Richmond Fed Shares Economic Outlook, Offers 10 Life and Career Tips at UVA Darden
Speaking at the University of Virginia Darden School of Business at a Leadership Speaker Series address, Barkin said he hoped his experience as someone who had been immersed in the nuts and bolts of business, hiring and firing, and raising and lowering prices, brought a unique perspective to the job.
Humility is a double-edged sword for some leaders, study shows
New research from the University of Notre Dame counters the theory that humble leaders are the best leaders, and in fact finds that those who display humility are viewed as less competent, independent and influential.